BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17088997)

  • 1. Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: evidence for a novel mechanism involving inhibition of BCL6 signaling.
    Faber AC; Chiles TC
    Int J Oncol; 2006 Dec; 29(6):1561-6. PubMed ID: 17088997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
    Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
    Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells.
    Kurosu T; Fukuda T; Miki T; Miura O
    Oncogene; 2003 Jul; 22(29):4459-68. PubMed ID: 12881702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?
    Bosga-Bouwer AG; van den Berg A; Haralambieva E; de Jong D; Boonstra R; Kluin P; van den Berg E; Poppema S
    Hum Pathol; 2006 May; 37(5):528-33. PubMed ID: 16647949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
    Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
    Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
    Jardin F; Ruminy P; Bastard C; Tilly H
    Pathol Biol (Paris); 2007 Feb; 55(1):73-83. PubMed ID: 16815642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOX expression in cutaneous B-cell lymphomas.
    Schrader AM; Jansen PM; Willemze R
    Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.
    Baron BW; Baron RM; Baron JM
    Biochim Biophys Acta; 2015 May; 1852(5):742-8. PubMed ID: 25557390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways.
    Shimizu T; Nakazato T; Xian MJ; Sagawa M; Ikeda Y; Kizaki M
    Biochem Pharmacol; 2006 Mar; 71(6):742-50. PubMed ID: 16427027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
    Morton LM; Purdue MP; Zheng T; Wang SS; Armstrong B; Zhang Y; Menashe I; Chatterjee N; Davis S; Lan Q; Vajdic CM; Severson RK; Holford TR; Kricker A; Cerhan JR; Leaderer B; Grulich A; Yeager M; Cozen W; Hoar Zahm S; Chanock SJ; Rothman N; Hartge P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1259-70. PubMed ID: 19336552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas.
    Bai M; Agnantis NJ; Skyrlas A; Tsanou E; Kamina S; Galani V; Kanavaros P
    Mod Pathol; 2003 May; 16(5):471-80. PubMed ID: 12748254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas.
    Faber AC; Dufort FJ; Blair D; Wagner D; Roberts MF; Chiles TC
    Biochem Pharmacol; 2006 Nov; 72(10):1246-56. PubMed ID: 16979140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrachromosomal rearrangement of chromosome 3q27: an under recognized mechanism of BCL6 translocation in B-cell non-Hodgkin lymphoma.
    Keller CE; Nandula S; Vakiani E; Alobeid B; Murty VV; Bhagat G
    Hum Pathol; 2006 Aug; 37(8):1093-9. PubMed ID: 16867873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
    Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
    Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
    Lossos IS; Levy R; Alizadeh AA
    Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.
    Saito M; Gao J; Basso K; Kitagawa Y; Smith PM; Bhagat G; Pernis A; Pasqualucci L; Dalla-Favera R
    Cancer Cell; 2007 Sep; 12(3):280-92. PubMed ID: 17785208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy.
    Elenitoba-Johnson KS; Jenson SD; Abbott RT; Palais RA; Bohling SD; Lin Z; Tripp S; Shami PJ; Wang LY; Coupland RW; Buckstein R; Perez-Ordonez B; Perkins SL; Dube ID; Lim MS
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7259-64. PubMed ID: 12756297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.